Direct-to-consumer virtual care company Hims & Hers Health announced it is acquiring telemedicine provider Zava, allowing it to expand into the UK and launch in Germany, France and Ireland.In a statement, the company said…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant’s obesity drug Wegovy and a Hims & Hers membership…
Continue Reading
Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of compounded GLP-1s for patients.
Compounded GLP-1s are custom-made by compounding pharmacies and include the same…
Continue Reading
Top News
Vanity prescription vendor Hims & Hers acquires Trybe Labs, an at-home lab testing provider that process customer self-collected blood samples.
The company says the acquisition will allow it to offer whole-body testing and…
Direct-to-consumer virtual care company Hims & Hers has acquired at-home lab testing facility Sigmund NJ LLC, also known as Trybe Labs.Hims & Hers said the acquisition of the New Jersey-based testing facility will allow customers to…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers is receiving backlash to its 60-second commercial dubbed “Sick of the System” that ran during the Super Bowl on Fox.The ad states that “obesity is America’s deadliest…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers Health reported a 77% year-over-year increase in revenue from $226.7 million in the third quarter of 2023 to $401.6 million in Q3 2024. The San Francisco-based company reported…
Continue Reading
Welcome to the May edition of Digital Health Digest!This month, we're spotlighting key developments in telehealth funding, weight loss programs, cybersecurity challenges, and advancements in wearable technology. Join us to explore how these innovations…
Continue Reading
As the nation grapples with a GLP-1 shortage, Hims & Hers is looking to improve access by making compounded GLP-1s available on its platform starting at $199 a month, the company announced Monday.
The San…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight loss management. The San Francisco-based company, which…
Continue Reading
